In 2017, the DOJ announced a full-throated response to the opioid crisis plaguing our country. In 2018 thus far, the DOJ continues to demonstrate its clear resolve to use every tool in the government’s toolbox to combat prescription drug abuse. There is reason to believe that the government may turn to holding officers, managing employees, and even general counsel of health systems accountable for illegal diversion of opioids under the Responsible Corporate Officer Doctrine ("RCO"). This may create a dilemma for a health care institution’s executive staff who in seeking to avoid prosecution of the business entity through “cooperation credit” by disclosing individual wrongdoing may simultaneously risk criminal sanction under the RCO because the conduct occurred under their supervision. Join us for an interactive discussion about this critically important topic. Specifically, our panel of Ballard attorneys will review the RCO as a potential weapon in the DOJ's arsenal to fight the opioid crisis and offer a solution to the dilemma a health care institution's executive staff invariably will face.

This webinar is the first in our 2018 Hot Topics in Health Care that we'll be hosting throughout the year. Look for our upcoming sessions where we'll be discussing Updates to the 21st Century Cures Act and Related Regulations and Regulations and Trends Impacting Telemedicine.

Date & TIme

Thursday, April 12, 2018
12:00 PM - 1:00 PM ET

Speakers

R. Stephen Stigall
Partner, White Collar Defense/Internal Investigations

Beth Moskow-Schnoll
Partner, White Collar Defense/Internal Investigations

This program is open to Ballard Spahr clients interested in data privacy and security in the digital world. There is no cost to attend. This program is not eligible for continuing education credits.

Please register at least two days before the webinar. Login details will be sent to all approved registrants. For more information, contact Brittney McKeever at mckeeverb@ballardspahr.com.

Register